Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty
- 17 June 1999
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 68 (2-3), 263-266
- https://doi.org/10.1016/s0165-2478(99)00050-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Immunization With Homologous LDL and Oxidized LDL on Early Atherosclerosis in Hypercholesterolemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995
- Antibody against oxidized low-density lipoprotein predicting myocardial infarctionArchives of Internal Medicine, 1994
- The oxidation hypothesis of atherosclerosisThe Lancet, 1994
- Autoantibodies to Oxidized Low Density Lipoproteins in Restenosis following Coronary AngioplastyJMIR AI, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosusThe Lancet, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1992
- Autoantibody against oxidised LDL and progression of carotid atherosclerosisThe Lancet, 1992